Boston Scientific shares rise 4.6% after Q2 results despite lower full-year outlook

The medical device maker posted higher second-quarter results and said it is starting a new restructuring plan announced earlier this week.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.